Showing results (351-360 of 1,188) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|January 12, 2017
Analyzing multiple endpoints in a confirmatory randomized clinical trial-an approach that addresses stratification, missing values, baseline imbalance and multiplicity for strictly ordinal outcomesHengrui Sun, Atsushi Kawaguchi, Gary KochPharmaceutical Statistics|October 4, 2022
A meta-analytic framework to adjust for bias in external control studiesDevin Incerti, Michael T Bretscher, Ray Lin, et al.Pharmaceutical Statistics|March 3, 2021
How to choose a time zero for patients in external control armsDaniel BackenrothPharmaceutical Statistics|March 3, 2021
Assessing and communicating heterogeneity of treatment effects for patient subpopulations: The hardest problem there isStephen J RubergPharmaceutical Statistics|February 23, 2021
On kernel machine learning for propensity score estimation under complex confounding structuresBaiming Zou, Xinlei Mi, Patrick J Tighe, et al.Pharmaceutical Statistics|December 28, 2021
Empirical likelihood confidence interval for sensitivity to the early disease stageHusneara Rahman, Yichuan Zhao, Pharmaceutical Statistics|January 21, 2022
Bayesian MCPModFrank Fleischer, Sebastian Bossert, Qiqi Deng, et al.Pharmaceutical Statistics|January 21, 2022
An adaptive design for early clinical development including interim decision for single-arm trial with external controls or randomized trialHeiko Götte, Marietta Kirchner, Johannes Krisam, et al.Pharmaceutical Statistics|January 7, 2022
Regulatory issues and the potential use of Bayesian approaches for early drug approval systems in JapanAkihiro Hirakawa, Hiroyuki Sato, Masataka Igeta, et al.Pharmaceutical Statistics|November 1, 2022
Regional efficacy evaluation in multi-regional clinical trials using a discounting factor weighted Z testXuanxuan Yu, Lixin Cai, Hao Yu, et al.Pageof 119